Finance Wales-backed Creo Medical raises $8.45m
Welsh electrosurgery devices manufacturer Creo Medical has raised $8.45m from Pentax Medical, as well as existing investors Finance Wales and the Angel CoFund.
Individual angel investors also participated in the round led by Japanese endoscopic imaging devices company Pentax Medical. The investment is the third round for Creo Medical, bringing the total raised to $20.7m.
With the fresh cash in hand, Creo will continue working towards achieving US regulatory approval for its platform, as well as build on the company's current portfolio of intellectual property.
Previous funding
Finance Wales led the first investment in Creo, injecting £1.36m in May 2012. The VC followed up its investment with a £3.5m round in November 2014, alongside the Angel CoFund.
Company
Founded in 2003, Creo is a Chepstow-based designer and developer of an electrosurgery platform, as well as instruments for endoscopy and minimally invasive surgery.
People
Richard Thompson led the deal for Finance Wales. David Woods is the chief marketing officer of Pentax. Craig Gulliford is the CEO of Creo.
More on UK / Ireland
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater